BioLineRx (BLRX) Reports Q3 Loss of $0.06/Share

BioLineRx (NASDAQ: BLRX) reported Q3 EPS of ($0.06), versus ($0.03) reported last year.

For earnings history and earnings-related data on BioLineRx (BLRX) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Danone SA (BN:FP) (DANOY) PT Raised to EUR63 at Deutsche Bank
• Bending Spoons closes IPO, raises ~$954M on Nasdaq